Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab

被引：38

作者：

Bruns, I

Fox, F

Reinecke, P

Kobbe, G

Kronenwett, R

Jung, G

Haas, R

机构：

[1] Univ Klinikum Dusseldorf, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany

[2] Univ Klinikum Dusseldorf, Inst Pathol, Dusseldorf, Germany

[3] Univ Klinikum Dusseldorf, Inst Diagnost Radiol, Dusseldorf, Germany

来源：

LEUKEMIA | 2005年 / 19卷 / 11期

关键词：

D O I：

10.1038/sj.leu.2403936

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1993 / 1995

页数：3

共 8 条

[1] Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10 [J].

Attygalle, A ;

Al-Jehani, R ;

Diss, TC ;

Munson, P ;

Liu, HX ;

Du, MQ ;

Isaacson, PG ;

Dogan, A .

BLOOD, 2002, 99 (02) :627-633

[2] Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide [J].

Dogan, A ;

Ngu, LSP ;

Ng, SH ;

Cervi, PL .

LEUKEMIA, 2005, 19 (05) :873-875

[3] Combination of antiangiogenic therapy with other anticancer therapies: Results, challenges, and open questions [J].

Gasparini, G ;

Longo, R ;

Fanelli, M ;

Teicher, BA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) :1295-1311

[4] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[5] Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature [J].

Pautier, P ;

Devidas, A ;

Delmer, A ;

Dombret, H ;

Sutton, L ;

Zini, JM ;

Nedelec, G ;

Molina, T ;

Marolleau, JP ;

Brice, P .

LEUKEMIA & LYMPHOMA, 1999, 32 (5-6) :545-552

[6] Mechanisms and future directions for angiogenesis-based cancer therapies [J].

Scappaticci, FA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3906-3927

[7] Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo [J].

Wang, ES ;

Teruya-Feldstein, J ;

Wu, Y ;

Zhu, ZP ;

Hicklin, DJ ;

Moore, MAS .

BLOOD, 2004, 104 (09) :2893-2902

[8] Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression [J].

Zhao, WL ;

Mourah, S ;

Mounier, N ;

Leboeuf, C ;

Daneshpouy, ME ;

Legrès, L ;

Meignin, V ;

Oksenhendler, E ;

Le Maignin, C ;

Calvo, F ;

Brière, J ;

Gisselbrecht, C ;

Janin, A .

LABORATORY INVESTIGATION, 2004, 84 (11) :1512-1519

← 1 →